Baracle Tab.®

DRUG2 trials

Sponsors

Dong-A ST Co., Ltd., Seoul St. Mary's Hospital

Conditions

Antiviral DrugHBVHBeAg-Positive Chronic Hepatitis BHematopoietic Stem Cell TransplantationHepatitis B Reactivation

Phase 4

Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis B

CompletedNCT01913431

Dong-A ST Co., Ltd.HBeAg-Positive Chronic Hepatitis B

Start: 2013-09-12End: 2015-11-06Updated: 2017-08-31

Unknown Phase

Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation

Enrolling by invitationNCT04942886

Seoul St. Mary's HospitalAntiviral Drug, HBV, Hematopoietic Stem Cell Transplantation +1

Start: 2021-08-21End: 2028-12-31Target: 226Updated: 2025-07-18